FDA reminds vets of Zycortal Suspension amid Percorten-V shortageAugust 2, 2018Due to a shortage of Percorten-V, which is approved for use as replacement therapy for mineralocorticoid deficit in dogs with Addison's Disease, the U.S. Food and Drug Administration's Center for Veterinary Medicine is reminding veterinarians that Zycortal Suspension is an alternative treatment option that is not currently in shortage. Elanco Animal Health, manufacturer of Percorten-V (desoxycorticosterone pivalate injectable suspension), reported a manufacturing issue with the product. "Elanco is experiencing a delay in production of …
SPONSORED CONTENTFind success with your parvovirus protocolDiscover our Canine Parvovirus Monoclonal Antibody: puppies treated with CPMA experienced a 93% real-world survival rate, and were able to head home from the clinic almost two days earlier.1,2 + Read More
